Arvee Labs' Board approved Q1 results: Revenue ₹17.23 Cr, Net Profit ₹1.69 Cr. The Scheme of Arrangement has been postponed for further review. The Board also finalized details for the upcoming Annual General Meeting.
Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Arvee Labs' Board approved Q4 & FY26 financial results. For FY26, Revenue was ₹31.51 Cr and Profit ₹2.53 Cr. Q4 Revenue stood at ₹10.80 Cr with Profit at ₹0.52 Cr. No other major decisions were announced.
